Author(s): Jeong Chun Phuoc, Albattat Ahmad, Azman Norhidayah, Zulhabri Othman
The sudden emergence of deadly novel corona virus known as SAR-CoV-2 resulted in a Covid-19 pandemic Covid-19 that witnessed a global lockdown in almost all walks of life from business to innovation activities Countries all over the world in Asia-Pacific, ASEAN, Europe, and Africa continent are scrambling to implement numerous cross-border measures -as a first line of defense- to stop and prevent contact, spread and infection from the deadly Covid-19. Since the covid-19 pandemic declaration by the United Nations World health organization WHO countries all over the world have implemented both medical and legal protocols in response to national security, public health, and economic meltdowns. As of June 7, 2021, the pandemic coronavirus COVID-19 has infected and killed over 174.116 million people and resulted in 3.75 million and 157.157 million positive cases totally recovered from this deadly illness. This paper seeks to explore the issues, and examine the various challenges in relation to COVID-19 innovation from an intellectual property in medical perspective within the areas of best medical screening, detection, containment, and the development of new vaccines.